Alexion

2 Key Reasons Morgan Stanley Upgraded Alexion Pharmaceuticals

Alexion Shares Under Pressure Amid Brazilian Office Raid; Barclays Says Buy The Dip

Barron's Picks And Pans: General Motors, Hess, Biotechs And More

Alexion Shares Under Pressure Amid Brazilian Office Raid; Barclays Says Buy The Dip

Barron's Picks And Pans: General Motors, Hess, Biotechs And More

Risks Remain For Alexion Even As Early Internal Investigation Results Seem Positive

Wild Short Interest Swings For These Three Biotech Stocks

Risks Remain For Alexion Even As Early Internal Investigation Results Seem Positive

Wild Short Interest Swings For These Three Biotech Stocks

Here's What Canaccord Learned After Spending A Day With Synageva's Management

How Wedbush Sees The Alexion–Synageva Deal

Alexion Recent News

Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices Positive

Alexion Spikes As Company Hires Goldman Sachs (ALXN)

Piper Jaffray Raises Its Price Target on Alexion (ALXN)

Alexion (ALXN) and Celgene (CELG) Ratings Discusses as Revlimid Maintenance Has Last Showing Before Approval

Alexion Pharmaceuticals Buy-Rated By Deutsche Bank